ARCHIVES

Letter to the Editor: Gensia Official Says No “Threat” Implied In Question Study

This article is from The Cancer Letter archive.

Vol. 21 No. 21 | May 26, 1995

Download PDF Visit The Full Archive

Related Articles

Tough Year Seen for Cooperative Groups; Priority Payment Questioned

December 2, 1988

Rituximab Prolonged Survival Of CLL In Phase III Study

September 24, 2010

IOM Report Lists Cancer CER Priorities

July 3, 2009

ASCO’s Lichter Says. Dingell, Stupak Urge FDA To “Act With Due Haste To Avoid Endangering Patients” Steered To ESAs.

March 7, 2008

Cancer Funding To Defense Dept. Is Threat To National Cancer Program, Broder Says

March 5, 1993

Biggest NCI Budget Brings Large Headache: More Commitments, Rising Costs, Opportunities

December 8, 1989